Polymer-coated bioactive glass S53P4 increases VEGF and TNF expression in an induced membrane model in vivo by Björkenheim, Robert et al.
IN HONOR OF LARRY HENCH
Polymer-coated bioactive glass S53P4 increases VEGF
and TNF expression in an induced membrane model
in vivo
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ABSTRACT
The two-stage induced-membrane technique for treatment of large bonedefects has
become popular among orthopedic surgeons. In the first operation, the bone defect
is filled with poly(methyl methacrylate) (PMMA), which is intended to produce a
membrane around the implant. In the second operation, PMMA is replaced with
autograft or allograft bone. Bioactive glasses (BAGs) are bone substituteswith bone-
stimulating and angiogenetic properties. The aim of our study was to evaluate the
inductive vascular capacity of BAG-S53P4 and poly(lactide-co-glycolide) (PLGA)-
coated BAG-S53P4 for potential use as bone substitutes in a single-stage induced-
membrane technique. Sintered porous rods of BAG-S53P4, PLGA-coated BAG-
S53P4 and PMMAwere implanted in the femur of 36 rabbits for 2, 4 and 8 weeks.
The expression of vascular endothelial growth factor (VEGF) and tumor necrosis
factor alpha (TNF) in the inducedmembranes of implantedmaterials was analyzed
with real-time quantitative polymerase chain reaction and compared with histol-
ogy. Both uncoated BAG-S53P4 and PLGA-coated BAG-S53P4 increase expression
ofVEGF andTNF, resulting inhigher amounts of capillary beds, comparedwith the
lower expressionofVEGFand less capillarybeadsobserved fornegativecontrol and
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PMMA samples. A significantly higher expression of VEGF was observed for
PLGA-coated BAG-S53P4 than for PMMA at 8 weeks (p\ 0.036). VEGF and
TNF expression in the induced membrane of BAG-S53P4 and PLGA-coated
BAG-S53P4 is equal or superior to PMMA, the ‘‘gold standard’’ material used in
the induced-membrane technique. Furthermore, the VEGF and TNF expression
for PLGA-coated BAG-S53P4 increased during follow-up.
Introduction
Treatment of bone defects, especially diaphyseal
bone defects, is still a major clinical challenge usu-
ally requiring transplantation of autologous or allo-
graft bone. Although autograft bone is one of the
most commonly transplanted tissues and the gold
standard in bone tissue reconstruction, it has dis-
advantages such as limited supply especially in
children and elderly patients. Bone harvesting may
also result in considerable donor site morbidity.
Allograft bone is abundantly available, but has its
own limitations, e.g., possible transmission of bac-
terial species [1].
Angiogenesis, including growth of blood vessels
from preexisting vessels, is a prerequisite for bone
formation. It is a complex phenomenon involving
oxygen and several cell types, such as mature and
progenitor endothelial cells, leukocytes and platelets,
as well as growth factors [2]. Vascular endothelial
growth factor (VEGF) is a multi-tasking cytokine that
is known to play a central role both in angiogenesis
and in fracture healing. It has also been suggested to
participate in the treatment of critical size defects by
increasing mineralization of the regenerated bone [3].
In 2000, Masquelet et al. [4] introduced a two-stage
technique for the treatment of diaphyseal bone
defects, which combines an induced-membrane
technique with the use of cancellous autografts. In the
first procedure, a poly(methyl methacrylate) (PMMA)
spacer is inserted into the bone defect. After the
insertion, a pseudo-synovial membrane will develop
around the spacer. During the second operation, the
spacer is removed and the defect is reconstructed
using autologous cancellous bone grafts. The induced
membrane is known to express various cytokines and
growth factors supporting bone formation such as
VEGF and tumor necrosis factor alpha (TNF). The
production of these factors and the effectiveness of
the induced membrane to support bone regeneration
have, however, been observed to continuously
diminish with time [5, 6].
Hench and Paschall [7] were the first to discover
the group of synthetic silica-based BAGs with bone
bonding properties in the late 1960s. Today, BAGs are
used as bone substitutes providing osteoconductive
and osteostimulative properties. These characteristics
are known to depend on controlled dissolution and
precipitation processes at the surface of the glass
starting immediately after implantation. The reaction
events commence with a rapid ion exchange of alkalis
at the glass surface to hydrogen ions in the solution
followed by dissolution and repolymerization of
soluble silica. Finally calcium phosphate nucleates
and crystallizes to hydroxyapatite at the surface of
the glass [8]. The surface reactions give rise to an
elevated pH of the solution in the interface between
the implant and tissue, which partly explains the
antibacterial properties observed for BAGs [9, 10].
Poly(a-hydroxy)acids such as polylactide (PLA),
polyglycolide (PGA) and poly(lactide-co-glycolide)
(PLGA) are commonly studied for applications in
bone regeneration. During their degradation process,
acidic products are released, with a subsequent
decrease in pH in the vicinity of the implanted
material, which may give rise to an inflammatory
response. However, many degradable polymers have
poor or lacking osteogenic and angiogenic activity.
By combining BAGs and degradable polymers as
composites, it was hypothesized that beneficial
properties from both materials can be utilized to
optimize the formation of an induced membrane and
subsequent bone regeneration.
The aim of this study was to evaluate the vascular
expression in a membrane induced by BAG or PLGA-
coated BAG, compared with a PMMA spacer or a
trauma (control) in an in vivo rabbit model.
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Materials and methods
Bioactive glass
BAG-S53P4, with a wt% composition of 53% SiO2,
23% NaO, 20% CaO and 4% P2O5, was made from
mixtures of Belgian sand for SiO2 and analytical
grades of Na2CO3, CaCO3 and CaHPO42H2O. The
glass was melted in a platinum crucible for 3 h at
1360 C. After casting in a preheated graphite mold,
the glass was crushed and re-melted for homoge-
nization. Annealed glass blocks were crushed and
sieved to a size range fraction of 300–500 lm. The
glass particles were sintered in graphite molds at
720 C in nitrogen atmosphere for 90 min to cylin-




(PLGA) named PDLG5002A with a 50/50 ratio
between DL-lactide and glycolide (Corbion, Gor-
inchem, the Netherlands) was used for coating one
end of the sintered BAG rods. The coating was car-
ried out by immersing approximately 2 mm of the
end of the BAG implant, in a dichloromethane solu-
tion containing 20 wt% PLGA. The partly coated
BAG-S53P4-PLGA implants were thereafter dried in
air and vacuum. The implants were gamma-sterilized
with a dose of 25 kGy.
Poly(methyl methacrylate), PMMA
Commercially available PMMA bone cement Pala-
cos ? G (Heraeus Medical GmbH, Wehrheim, Ger-
many) was mixed according to the manufacturer’s
instructions. PMMA rods with a length of 15 mm and
a diameter of 5 mm size were made under sterile
conditions and sterilized in an autoclave oven prior
to animal surgery.
Animals and surgery
Thirty-six skeletally mature rabbits (NZW, Harlan
Laboratories) were used. The animal study was
approved by the Animal Experimental Board of
Finland (ESAVI/440/04.10.07/2014), and the princi-
ples of laboratory animal care of the University of
Helsinki were strictly followed.
The operations were performed under general
anesthesia using subcutaneous medetomidine
hydrochloride and ketamine hydrochloride. A bone
defect was performed by drilling a 6-mm horizontal
hole from the lateral to the medial part of the distal
metaphyseal region of the femur. One 5 9 15 mm
rod of either BAG-S53P4, BAG-S53P4-PLGA or
PMMA was implanted in the created bone defect.
The BAG-S53P4-PLGA rods were implanted placing
the coated end in the cortical region of the bone
against soft tissue. Three parallel experiments for
each combination of rod and time point were used.
Three defects per time point were left empty for
control. Cefuroxime, buprenorphine and carprofen
were given for 3 days postoperatively to prevent
infections and to relieve pain. Postoperatively at 2, 4
and 8 weeks, the animals were euthanized with an
overdose of pentobarbital. The membranes induced
at the end of the implants as well as at the site of the
control hole were collected. For histochemistry, the
samples were stored in 10% formalin overnight, then
washed and stored in 70% EtOH to be further pro-
cessed. Samples for real-time quantitative poly-
merase chain reaction (RT-qPCR) analysis were
stored in RNA later solution (AM7020) at 4 C over-
night and then stored in sterile tubes at -80 C to
await further processing.
Real-time quantitative polymerase chain
reaction (RT-qPCR)
Induced-membrane tissue samples of 30–50 mg were
homogenized in Trizol solution (Invitrogen/Life
Technologies Paisley, UK) with an Ultra-Turrax
homogenizer. Upper aqueous layer containing RNA
was separated by centrifugation with chloroform and
combined with the RNeasy Mini Kit (Qiagen,
Valencia, CA, USA) for total RNA isolation according
to the manufacturer’s instructions. cDNA was syn-
thesized from 600 ng of isolated RNA using an
iScript cDNA synthesis kit (Bio-Rad, Hercules, CA,
USA) and diluted 1:3 with RNA-free water. cDNA
synthesis was performed two separate times from the
same total RNA samples, and qPCR was performed
twice for both samples using iQ5 real-time PCR
detection system (Bio-Rad). The reaction mixture for
qPCR was 10 ll of iQ SYBR green, 7 ll of water, 2 ll
of cDNA (20 ng) and 1 ll of 5 lM primers. The pri-
mer sequences were as follows; VEGF (247 bp; Acc
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no. AY196796): sense 50-CACCCATGGCAGAAGAA
GGA-30, antisense 50-ATCCGCATGATCTGCATGG
T-30 and for TNF (281 bp; Acc no. NM_001082263):
sense 50-GAGTCCCCAAACAACCTCCA-30, anti-
sense 50-TGAGTGAGGAGCACGTAGGA-30. As a
reference gene, GAPDH (207 bp; Acc no.
NM_001082253) was used with the following
sequence: sense 50-CGAGCTGAACGGGAAACTCA-
30, antisense 50-TGGGTGGCACTGTTGAAGTC-30.
Results were calculated with Gene Expression Macro
for Microsoft Excel, version 1.1 (Bio-Rad).
Hematoxylin and eosin staining
Samples of the induced membrane were after har-
vesting fixated in 10% formalin overnight for
hematoxylin and eosin (H&E) staining. The samples
were processed with KOS multifunctional micro-
wave tissue processor (Milestone Srl, Sorisole BG,
Italy), embedded in paraffin with Microm EC 350
Tissue Embedding Center (Thermo Scientific, Kala-
mazoo, MI, USA) for producing paraffin blocks and
cut into 3-lm sections using RM 2255 Microtome
(Leica Microsystems, Wetzlar, Germany). Tissue
sections were deparaffinized in xylene and hydrated
through a descending alcohol series to water using
automatic stainer (Varistain XY, Shandon, Life Sci-
ences International LTD, Cheshire, England). This
was followed by 10-min incubation in hematoxylin
to stain cell nuclei and 5 min in 0.5% eosin to stain
cytoplasm and extracellular matrix, and dehydrated
in an ascending alcohol series, cleared in xylene and
mounted.
The H&E stained sections were evaluated for the
presence of capillary beds using a Leica DM6000
B/M light microscope connected to a digital camera
(DFC420 and DFC365FX; Leica Microsystems). Ima-
ges with 109magnifications were obtained from each
sample and time point. In order to get the best result
for each type of membrane, one representative sam-
ple from each treatment group and time point was
selected and a manual capillary vessel count was
preformed from three different regions with the most
capillaries seen located in the surrounding of the
lining of the membrane using ImageJ software (ver-
sion 2.0.0-rc-43/1.51h, open-source image processing
software). This was done because there were appar-
ent differences in the quality of samples, even
between membranes of the same type and time point.
Statistical analysis
One rabbit deceased 3 days after the surgical proce-
dure from diarrhea for an unknown reason, resulting
in duplicate samples for PMMA at 2 weeks com-
pared to triplicates for BAG-S53P4 and BAG-S53P4-
PLGA. One-way ANOVA analysis followed by
Tukey’s multiple comparison post hoc follow-up test
was used to calculate statistical differences using
Prism software (version 7.0a, GraphPad Software,
Inc.). p\ 0.05 was chosen as the threshold of statis-
tical significance.
Results
Real-time quantitative polymerase chain
reaction (RT-qPCR)
A high expression of VEGF for the control membrane
was observed at 2 weeks, but the expression levels
rapidly declined, not being applicable for analysis at
8 weeks. This was in contrast to the PMMA treated
group, for which a low but only slightly decreasing
expression of VEGF was observed up to 8 weeks. The
VEGF expression for the uncoated BAG-S53P4
induced membranes was highly up-regulated at
2 weeks being significantly higher compared to
PMMA (p = 0.043) and PLGA-coated BAG-S53P4
(p = 0.018), but declined to the level for PMMA and
coated BAG-S53P4 at the 4-week time point. Inter-
estingly, the PLGA-coated BAG-S53P4 changed the
pattern of VEGF expression and, rather than declin-
ing over time, a steady increase from low to high
VEGF expression over the 8-week period could be
observed being significantly higher at the 8-week
time point compared to the 2-week time point
(p = 0048). Furthermore, at 8 weeks, the VEGF
expression in PLGA-coated BAG-S53P4 samples was
significantly higher than in PMMA membranes
(p = 0036). While the difference in VEGF expression
between PLGA-coated BAG-S53P4 and uncoated
BAG-S53P4 membranes was apparent, it did not
reach statistical significance. However, a clear trend
for statistical significance was observed (p = 0066)
between BAG-S53P4-PLGA and BAG-S53P4 at the
8-week time point.
The TNF expression for the control drill samples
was low throughout the follow-up, being inadequate
for analysis at 8 weeks. The TNF expression for
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PMMA reached its peak at 2 weeks and was appar-
ently higher compared to uncoated and coated BAG-
S53P4, with a declining trend toward the end of the
follow-up. At this 2-week time point, PMMA showed
a trend for statistical significance when compared to
BAG-S53P4-PLGA (p = 0056). This was in contrast to
the PLGA-coated BAG-S53P4, for which an increase
in TNF expression, consistent with the VEGF
expression pattern for PLGA-coated BAG-S53P4, was
observed throughout the follow-up.
The results of qPCR are summarized in Figs. 1 and
2.
Histology
A high presence of capillary beds was observed at
2 weeks in the control drill membrane specimens.
The number declined during follow-up and at
8 weeks only few capillary beds were observed
(p = 0.014). The PMMA-induced membrane showed
a stable capillary count at every time point, although
with a declining trend. The BAG-S53P4-induced
membrane had a clear peak of capillary bed density
at 2 weeks, which declined to the level of the PMMA-
induced membrane at 4- and 8-week time point.
Comparing the different membranes of BAG-S53P4,
the 2-week induced membrane had significantly
more capillaries than the 4-week (p = 0.025) and the
8-week (p = 0.035) induced membranes. The BAG-
S53P4-PLGA membranes were similar to the PMMA
at the 2-week time point. However, at 8 weeks the
BAG-S53P4-PLGA-induced membrane had clearly
the highest number of capillary vessels compared to
all other induced membranes. This observation was
Figure 1 VEGF (a) and TNF
(b) relative expression levels
over time in BAG-S53P4-
PLGA, BAG-S53P4 and
PMMA-induced membrane
tissue samples. Box showing
median with interquartile
range, bars showing min to
max; * statistical significance
p\ 0.05.
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statistically significant for the control membrane
(p = 0.0058) and PMMA membrane (p = 0.045).
These results are shown in Fig. 3. The 8-week H&E
stains for each type of induced membrane are shown
in Fig. 4a–d.
Figure 2 VEGF (a) and TNF
(b) relative expression levels
at specific time points in BAG-
S53P4-PLGA, BAG-S53P4
and PMMA-induced
membrane tissue samples. Box
showing median with
interquartile range, bars
showing min to max; *
statistical significance
p\ 0.05; # statistical trend
p\ 0.07.
cFigure 3 The capillary vessel count results at different time points
frommost representative control membrane tissue sample and BAG-
S53P4-PLGA, BAG-S53P4 and PMMA-induced membrane tissue
samples. Bars show mean SEM. a Illustration of capillary count at
different time points. b Illustrates the capillary count from the three
regions of the same sample separately over time.
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Discussion
We evaluated the pro-angiogenetic activity as VEGF
expression in an induced membrane formed on the
soft tissue interface of BAG-S53P4 and PLGA-coated
BAG-S53P4 rods in comparison with PMMA, the
gold standard material used in the two-stage
induced-membrane technique. Of the combinations
of materials tested, only the BAG-S53P4-PLGA-in-
duced membrane showed a continuous increase in
VEGF expression, which was observed to be at its
highest level at 8 weeks. To our knowledge, a similar
continuous increase in VEGF expression has not been
reported earlier. During the same time period, the
VEGF expression of the PMMA-induced membrane
decreased constantly, in concordance with observa-
tions in a comparable study in humans [5] as well as
in an in vivo rabbit study [6].
The pro-angiogenetic potential that we observed
for BAGs, i.e., the increase in VEGF expression, is
consistent with several previous in vitro and in vivo
studies [11–13]. Particles of BAG-45S5 and BAG-
S53P4 have been shown to increase VEGF secretion
from human fibroblast cells in a size- and
concentration-dependent manner. For BAG-S54P4, an
enhanced VEGF release was observed for particles of
both 0.5–0.8 and 1–2 mm size, whereas a particle size
of 2–3.15 mm led to an inhibition of VEGF release
[13]. Fibroblasts stimulated with BAG-S45S5 particles
are known to increase proliferation of human dermal
microvascular endothelial cells and enhance neovas-
cularization [14]. BAG-S45S5 has also been found to
increase the pro-angiogenetic properties of degrad-
able polymers. PLGA spheres containing 10% (w/v)
BAG-45S5 particles have been demonstrated to
stimulate an increase in VEGF by fibroblasts [15].
Compared with pure poly(D,L-lactide) PDLLA, an
addition of BAG to a PDLLA matrix also stimulated
angiogenic signaling in fibroblasts by increasing
VEGF secretion in a dose-dependent manner.
It is not known how PLGA coating of BAGs affects
VEGF expression in an induced membrane. In gen-
eral, it is, however, known that coating BAGs with a
biodegradable polymer decreases the dissolution rate
of the glass [16]. The expression pattern in the
induced membrane may be explained as follows:
According to the expected chemical reactions at the
PLGA-coated BAG-S53P4 surface, the polymer will
Figure 4 Histology demonstrating capillary beds of the induced
membrane formed at 8 weeks on BAG-S53P4-PLGA, BAG-
S53P4 and PMMA implants and the negative control. Scale bar is
set to 100 lm. The asterisk indicates the surface against implant.
a Control. b PMMA. c BAG-S53P4. d BAG-S53P4-PLGA.
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degrade, subsequently increasing the angiogenic
potential of the BAG. Simultaneously with the
degradation of the polymer, the surface reactions at
the BAG will occur as a continuous release of Ca, Na,
P and Si from the BAG in solution has been demon-
strated to occur after implantation, thus continuing
the increase in VEGF expression observed for BAGs
[17].
The higher VEFG expression of the BAG-S53P4-
induced membrane compared to the BAG-S53P4-
PLGA-induced membrane at 2 weeks suggests that
the ions released from BAG-S53P4 positively affect
the VEGF expression and that the polymer effectively
slows down the ion release and the gene expression.
This retarding effect can depend on the polymer
barrier preventing contact with the uncoated part of
the BAG-S53P4 scaffold or the ability of the polymer
degradation products to neutralize the interfacial
solution and thus slow down the ion release rate from
the glass. At prolonged implantation, the polymer
will partly degrade allowing a higher ion release
from the BAG-S53P4-based structure. This implies
that the partly polymer-coated scaffold enables a
continuous release of ions over a longer period of
time at concentrations high enough to support VEGF
expression than the uncoated scaffold.
The Ca2? ion is known to play a significant role in
the VEGF-regulated multifunctional signaling path-
way [2], which is known to influence the mobilization
of Ca2?. Bone marrow-derived progenitor cells,
important in angiogenesis, have been demonstrated
to respond to changes in extracellular calcium,
through a calcium-sensing receptor as well. The high
VEGF expression for both BAG-S53P4 and BAG-
S53P4-PLGA may depend on the ion release of Ca2?,
which takes place at the surface of the glass. Scaffolds
with incorporated BAGs have also been demon-
strated to stimulate neovascularization. The mecha-
nisms are unknown, but they are thought to depend
on the Ca2? ion release at the glass surface. The
increase in VEGF secretion from human fibroblast
cells induced by BAG-S53P4 has also been demon-
strated to depend on the size of the reacting glass
granules, in favor of smaller particles. This may be
explained by higher concentrations of ions released
from the smaller particles possessing a higher surface
area to solution volume ratio, influencing the disso-
lution process of the glass.
In 1970, Carlisle showed that silicon affects bone
growth by demonstrating disturbed bone formation
in silicon-deprived chicken. It has been postulated
that silicon also may affect angiogenesis and neo-
vascularization. Akermanite (Ca2MgSi2O7), a silicate
bioceramic, has been demonstrated to cause Si-ion-
stimulated proliferation of human aortic endothelial
cells. A more rapid increase in blood vessel contain-
ing Haversian and Volkmann’s canals has been
observed for akermanite in comparison with trical-
ciumphosphate implants in vivo, indicating that sili-
con may affect neovascularization [18]. A bioactive
material only containing silicon and calcium has also
been demonstrated to stimulate angiogenesis in a
fibroblast and endothelial cell culture, and thus, it has
been postulated that silicon may play an important
role in initiating angiogenesis [19]. However, in both
of the previously mentioned studies, the materials
also consisted of calcium, which affects angiogenesis.
Also contradictory pro-angiogenetic observations
for silicon have been reported. Silica nanoparticles
(SiNPs) have been demonstrated to disturb
endothelial cell homeostasis and to impair angio-
genesis due to enhanced autophagic activity. SiNPs
seem to have an inhibitory effect on angiogenesis on
zebrafish via a down-regulation of the VEGF2/Erk1/
2 signaling pathway [20]. Mesoporous silica nano-
spheres have been reported not to have on obvious
effect on VEGF stimulation of human bone marrow
stromal cells [21]. These anti-angiogenetic findings
may, however, be dependent of the size of the
particles.
In a study on the response of osteoblast-like cells to
17 metals, an excellent cell proliferation and a high
ability to affect collagen synthesis have been
observed for silicon [22]. It is known that silicon
deprivation decreases collagen formation in bone and
it has also been suggested that silicon plays an
important role in wound healing. As blood vessels
contain collagen, it can thus be speculated that silicon
may play an important part in neovascularization
due to its relevance in collagen formation and per-
haps a lesser part in VEGF stimulation.
In the induced-membrane technique, the second
operation is usually performed between 4 and
8 weeks after the first procedure, but it has been
speculated that the optimal time for performing the
second-stage surgery may be within a month after
implantation of PMMA. This is based on histological
observations showing that the vascularization in
PMMA-induced membranes is ample in one-month-
old samples and decreases to less than 60% in three-
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month-old samples [5]. This finding is supported by
our study, as the inductive capacity of PMMA on
VEGF expression seems to be lowest at 8 weeks, the
time when many operations are performed. In our
study, the PMMA-induced membranes and mem-
branes of the control drill showed their highest cap-
illary density at 2 weeks, with a decreasing trend
during follow-up, compared with the BAG-induced
membranes, which showed high capillary density
throughout the follow-up.
Fracture healing and bone regeneration are com-
plex processes that involve coordinated interplay
between the cells of the innate immune system and
various osteoprogenitor cells [22, 23]. Fracture heal-
ing is initiated by an acute inflammation character-
ized by production of pro-inflammatory cytokines,
e.g., TNF that regulate the recruitment and differen-
tiation of mesenchymal stem cells along the chon-
drogenic and osteogenic lineages. Indeed, a short
period of TNF production is crucial for bone regen-
eration. In the subsequent state of fracture healing,
ingrowth of vasculature in the fracture site is crucial
for the bone regeneration. This angiogenesis is
mediated by growth factors such as VEGF. Thus,
both TNF and VEGF have been shown to play a key
role in the various stages of bone regeneration
[22, 23].
The expression of TNF for PMMA constantly
decreased during the 8-week period, in accordance
with previously described observations of low VEGF
expression for PMMA. For BAG-S53P4, which clini-
cally is known to be a well-tolerated bone substitute
without observed inflammatory response, an increase
in TNF expression was observed at 4 weeks.
A limitation of the study is that it focuses on
comparison of inflammatory and angiogenic respon-
ses elicited by the materials, while the osteogenic
potential of the induced membranes was not evalu-
ated. Additionally, the sample size per group is
small, and thus, the results need to be interpreted
cautiously.
In summary, our study reveals that both uncoated
and coated porous BAG-S53P4 implants positively
affect the expression of VEGF and TNF, resulting in
higher amounts of capillary beds observed in histo-
logical samples, compared with the lower expression
of VEGF and less capillary beads observed in control
and PMMA samples.
The induced membrane of PMMA is known to
have angiogenetic-improving properties, which,
however, appear to decrease over time. In the
induced membrane of PLGA-coated BAG-S53P4, we
observed an inductive expression of VEGF that
increased with time. At 8 weeks, the expression of
VEGF was significantly higher for coated BAG-S53P4
than for PMMA (p\ 0.036). PLGA-coated BAG-
S53P4 is thus an attractive biomaterial for further
development of a one-stage induced-membrane
technique, as the composite material carries both
angiogenic and osteoregenerative properties.
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Leskelä H-L (2013) The mechanism of action of induced
membranes in bone repair. J Bone Joint Surg 95:597–604
[6] Pelissier PH, Masquelet AC, Bareile R, Pelissier SM,
Amedee J (2004) Induced membranes secrete growth factors
including vascular and osteoinductive factors and could
stimulate bone regeneration. J Orthop Res 22:73–79
[7] Hench LL, Paschall HA (1973) Direct chemical bond of
bioactive glass–ceramic materials to bone and muscle.
J Biomed Mater Res Symp 4:25–42
[8] Hench LL (2006) The story of bioglass. J Mater Sci Mater
Med 17:967–978
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